Abstract
Truly mixed corticomedullary tumors (MCMTs) are extremely rare and present as a single tumor mass composed of an intimately admixed population of both adrenal cortical cells and pheochromocytes. The current study describes the first case of a mixed corticomedullary adrenal carcinoma. In addition, we also review the published data on MCMTs to determine their clinical features, biochemical characteristics, pathological findings, and management. In order to compose this review, a search of the international literature for MCMTs was conducted. Fifteen related articles were found. The clinical and pathological information was obtained for all reported cases. MCMTs were found almost exclusively in females. In the vast majority of patients, the symptoms were related to the tumor’s hormone hypersecretion. Hypertension and diabetes were present in 80 and 40 % of cases, respectively. Cushing’s syndrome was reported in eight cases (53.33 %). A final diagnosis was made in all cases after surgery based on the pathological results. As of the writing of this article, all published cases of MCMTs had benign clinical behavior, with no instances of metastasis or death due to the tumor. MCMTs are currently considered to be benign tumors. Ours is the first case of malignant MCMT reported in the literature. The potential for malignancy should therefore be considered for these tumors.
Similar content being viewed by others
Abbreviations
- MCMT:
-
Mixed corticomedullary tumor
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- NSE:
-
Neuron-specific enolase
- MCTC:
-
Mixed corticomedullary carcinoma
- MeSH:
-
Medical subjected headings
References
Bliss RD, Lennard TWJ. The adrenal glands in endocrine surgery. 3rd ed. Philadelphia: Elsevier Saunders; 2006. p. 80–103.
Singh M, Mandal S, Kakkar AK, Khurana N, Garg A. Mixed corticomedullary tumour with myelolipoma: a rare coexistence. Pathology. 2010;42:589–91.
Wieneke JA, Thompson LDR, Heffess CS. Corticomedullary mixed tumor of the adrenal gland. Ann Diagn Pathol. 2001;5:304–8.
Lau SK, Chu PG, Weiss LM. Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: an unusual corticomedullary tumor of adrenal gland. Ann Diagn Pathol. 2011;15:185–9.
Alexandraki KI, Michail OP, Nonni A, Diamantis D, Giannopoulou I, Kaltsas GA, et al. Corticomedullary mixed adrenal tumor: case report and literature review. Endocr J. 2009;56:817–24.
Kimura T, Usui T, Inamoto S, Minamiguchi S, Okuno H, Sasano H, et al. Pheochromocytoma with subclinical Cushing’s syndrome caused by corticomedullary mixed tumor of adrenal gland. J Clin Endocrinol Metab. 2009;94:746–7.
Bonacci R, Gigliotti A, Baudin E, Wion-Barbot N, Emy P, Bonnay M, et al. Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Br J Cancer. 1998;78:546–9.
Mathison DA, Waterhouse CA. Cushing’s syndrome with hypertensive crisis and mixed adrenal cortical adenoma-pheochromocytoma (corticomedullary adenoma). Am J Med. 1969;47:635–41.
Akai H, Sanoyama K, Namai K, Miura Y, Murakami O, Hanew K, et al. A case of adrenal mixed tumor of pheochromocytoma and adrenocortical adenoma presenting diabetes mellitus and hypertension (in Japanese with English abstract). Jpn J Endocrinol: Nihon NaibunpiGakkaiZasshi. 1993;69:659–69.
Chu AY, Livosli VA, Fraker DL, Zhang PJ. Corticomedullary mixed tumor of adrenal gland with concurrent adrenal myelolipoma. Arch Pathol Lab Med. 2003;127:329–32.
Delèvaux I, Cabane J, Picard O, Bénit C, Lebas J, Nordlinger B, et al. Mixed corticomedullary tumor. Presse Med. 1998;27:1272–4.
Lee P, Bradbury RA, Sy J, Hughest L, Wong L, Falk G, et al. Phaeochromocytoma and mixed corticomedullary tumour—a rare cause of Cushing’s syndrome and labile hypertension in a primigravid woman postpartum. Clin Endocrinol. 2007;68:492–4.
Ma WY, Yang AH, Chang YH, Lin LY, Lin HD. Coexistence of adrenal Cushing syndrome and pheochromocytoma in a “corticomedullary adenoma”: a case report and review of the literature. Endocrinologist. 2007;17:341–5.
Michal M, Havlicek F. Corticomedullary tumors of the adrenal glands. Report of two cases. Association of corticomedullary tumor with spindle cell sarcoma. Pathol Res Pract. 1996;192:1082–9.
Trimeche Ajmi S, Chadli Chaieb M, Mokni M, Braham R, Ach K, Maaroufi A, et al. Corticomedullary mixed tumor of the adrenal gland. Ann Endocrinol (Paris). 2009;70:473–6.
Ohta TI, Motoyama T, Imai T, Komeyama T, Watanabe H. Cortico-medullary mixed tumor (Pheochromocytoma and cortical adenoma) of the adrenal gland. J Urol Pathol. 1995;3:157–64.
Hu WL, Cao QY, He HX, L J, Li QR, Wang YL, et al. Misdiagnosis of corticomedullary mixed pathological changes in adrenals: report of 4 cases. Di Yi Jun Yi Da Xue Xue Bao. 2002;22:1145–7.
Li ZL, Sun D, Kong CZ. Diagnosis and treatment for the corticomedullary mixed tumor of adrenal gland. ZhonghuaWai Ke Za Zhi. 2009;47:1239–41.
Sangoi A, McKenney J. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Pathol. 2010;34:423–32.
Stachowiak MK, Rigual RJ, Lee PHK. Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferse mRNA levels in the sympathoadrenal system by the pituitary–adrenocortical axis. Brain Res. 1998;427:275–86.
Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev. 1998;19:101–43.
Schinner S, Bornstein SR. Cortical-chromaffin cell interactions in the adrenal gland. Endocr Pathol. 2005;16:91–8.
Andersen KF, Altaf R, Krarup-Hansen A, Kromann-Andersen B, Horn T, Christensen NJ, et al. Malignant pheochromocytomas and paragangliomas—the importance of a multidisciplinary approach. Cancer Treat Rev. 2011;37:111–9.
Conflict of interest
All authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Michalopoulos, N., Pazaitou-Panayiotou, K., Boudina, M. et al. Mixed corticomedullary adrenal carcinoma. Surg Today 43, 1232–1239 (2013). https://doi.org/10.1007/s00595-012-0458-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-012-0458-4